Health & Biotech Creso wraps up Health House acquisition, expands global cannabis footprint November 22, 2022 Special Report: Cannabis player Creso Pharma has taken the final step in its acquisition of Health House International (ASX:HHI) by… Stellar start to FY23 for Wellnex with revenue up by 60% November 21, 2022 Special Report: Health and wellness company Wellnex Life (ASX:WNX) is kicking away from the main peloton of the ASX health and… ASX Health Stocks: Zelira to test its own drug against a Big Pharma’s multi-billion dollar revenue star November 21, 2022 Cannabis stock, Zelira Therapeutics (ASX:ZLD), announced that it has completed the enrolment for its Diabetic Nerve Pain Drug Trial. Exopharm and EU bioprocessing leader Sartorius BIA Separation are about to go all-in on large-scale exosome production November 21, 2022 Special Report: Exopharm is joining forces with a global bioprocessing leader - and Slovenia’s best performing company - with an… ScoPo’s Powerplays: All looking good on the ground for ASX health stocks November 18, 2022 ASX health stocks are up for the week with Power confident of a much needed end of year rally Power… Incannex initiates big clinical trial and details FDA plans for pivotal clinical trials for sleep apnoea drug November 18, 2022 Special Report: Incannex Healthcare commits to a 116-person bioavailability/ bioequivalence (BA/BE) study and will submit an investigational new drug application… ASX Health Stocks: Argenica’s Phase 1 trial takes crucial step forward after drug safety confirmed November 18, 2022 Argenica granted approval to progress in Phase 1 trial Respiri is running a pilot program for wheezo in Minnesota … On the nose – Osteopore taps into lucrative rhinoplasty market with bioresorbable polymer scaffold November 17, 2022 Special Report: Osteopore is continuing its drive to be a major player in rhinoplasty, marketing its bioresorbable polymer scaffold to… ASX Health Stocks: UBI graces front cover of world-leading Journal; Neurotech preps Phase II/III trial November 17, 2022 Universal Biosensors (ASX:UBI) says that work done on its Tn Antigen cancer biosensor has been published in the 'ACS Sensors'… Check Up: The TGA is 100pc cool with the world’s first faecal transplant, oral delivery being studied November 17, 2022 The TGA has made a landmark approval on faecal transplant therapy South Australian BiomeBank has managed to cultivate a ‘faecal… Next» « Previous